Skip to main content
. 2018 Feb 15;118(6):878–886. doi: 10.1038/bjc.2017.492

Table 1. Univariate logistic regression analysis indicating associations between covariates of interest and tumour response to neoadjuvant therapy.

  Responders/N % OR 95% CI P-value
Age (years)     1.03 1.00;1.06 0.0478
Gender          
 Female 25/54 46.3 1.28 0.67;2.45 0.4477
 Male 49/122 40.2 1    
Distance from anal verge (cm)     0.94 0.84;1.06 0.3177
Total radiotherapy dose (Gy)          
 <50.40 11/24 45.8 1.46 0.54;3.93 0.4564
 50.40 39/91 42.9 1.29 0.63;2.64 0.4823
 >50.40 18/49 36.7 1    
Interval between CRT and surgery (days)     0.99 0.79;1.25 0.9551
Fluoropyrimidine          
 Alone 42/94 44.7 1.39 0.73;2.63 0.3133
 +other drugs 25/68 36.8 1    
 No 2/6 33.3 0.86 0.15;5.04 0.8672
cTNM          
 I–II 15/25 60.0 2.30 0.97;5.47 0.0591
 III 58/147 39.5 1    
TERT T0          
 >median 39/87 44.8 1.29 0.71;2.36 0.4066
 ⩽median 34/88 38.6 1    
TERT T1          
 ⩽median 28/59 47.5 1.48 0.71;3.09 0.2985
 >median 22/58 37.9 1    
TERT ΔT0–T1          
 >0 21/43 48.8 1.53 0.72;3.29 0.2708
 ⩽0 28/73 38.4 1    
TERT T2          
 =0 48/69 69.6 8.38 4.03;17.41 <0.0001
 >0 18/84 21.4 1    
TERT T2          
 ⩽median 51/77 66.2 7.98 3.82;16.66 <0.0001
 >median 15/76 19.7 1    
TERT ΔT0–T2          
 >0 41/70 58.6 3.42 1.74;6.69 0.0003
 ⩽0 24/82 29.3 1    
CEA T0          
 ⩽median 39/86 45.3 1.22 0.66;2.24 0.5213
 >median 34/84 40.5 1    
CEA T2          
 ⩽median 35/79 44.3 1.19 0.62;2.29 0.5957
 >median 28/70 40.0 1    
CEA ΔT0–T2          
 ⩽0 24/52 46.1 1.27 0.65;2.51 0.4840
 >0 39/97 40.2 1    

Abbreviations: CEA=carcinoembryonic antigen; CI=confidence inteval; CRT=chemoradiotherapy; cTNM=clinical Tumour, Node, Metastasis classification; OR=odds ratio; TERT=telomerase reverse transcriptase.

Notes: Median levels of TERT were 148, 98 and 42 copies per ml at T0, T1 and T2 time point, respectively. Median levels of CEA were 2.0 and 1.6 ng ml−1 a T0 and T2 time point, respectively.